Placebo-Controlled Trials of Blood Pressure–Lowering Therapies for Primary Prevention of Dementia
Authors:
- Jan A. StaessenJSJan A. Staessen
- Lutgarde ThijsLTLutgarde Thijs
- Tom RichartTRTom Richart
- Augustine N. OdiliAOAugustine N. Odili
- 1 February 2011
- journal article
- letter
- Published by Wolters Kluwer Health in Hypertension
- Vol. 57 (2) , e6-7
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Telmisartan to Prevent Recurrent Stroke and Cardiovascular EventsNew England Journal of Medicine, 2008
- Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trialThe Lancet Neurology, 2008
- Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trialThe Lancet, 2007
- Less Atherosclerosis and Lower Blood Pressure for a Meaningful Life Perspective With More BrainHypertension, 2007
- Global prevalence of dementia: a Delphi consensus studyThe Lancet, 2005
- Do Thiazide Diuretics Confer Specific Protection Against Strokes?Archives of internal medicine (1960), 2003
- Effects of Blood Pressure Lowering With Perindopril and Indapamide Therapy on Dementia and Cognitive Decline in Patients With Cerebrovascular DiseaseArchives of internal medicine (1960), 2003
- The Study on Cognition and Prognosis in the Elderly (SCOPE)Journal Of Hypertension, 2003
- Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trialThe Lancet, 1998
- Prevention of Stroke by Antihypertensive Drug Treatment in Older Persons With Isolated Systolic HypertensionJAMA, 1991